Baseline CSF BDNF levels of AMS patients were also significantly lower than those of non-AMS patients, showed weak correlation with third year EDSS and total attack numbers in a 3-year follow-up period, and were associated with NEDA-3. Here, BDNF is linked to ablepharon macrostomia syndrome.